News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,539 Results
Type
Article (49824)
Company Profile (278)
Press Release (686437)
Multimedia
Podcasts (62)
Webinars (12)
Section
Business (212328)
Career Advice (2098)
Deals (36537)
Drug Delivery (104)
Drug Development (83639)
Employer Resources (173)
FDA (16984)
Job Trends (15720)
News (359333)
Policy (34701)
Tag
Academia (2782)
Accelerated approval (5)
Adcomms (23)
Allergies (88)
Alliances (51612)
ALS (93)
Alzheimer's disease (1439)
Antibody-drug conjugate (ADC) (129)
Approvals (16987)
Artificial intelligence (276)
Autoimmune disease (22)
Automation (16)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (191)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (290)
Cancer (2314)
Cardiovascular disease (186)
Career advice (1761)
Career pathing (31)
CAR-T (154)
Cell therapy (429)
Cervical cancer (21)
Clinical research (67921)
Collaboration (859)
Company closure (1)
Compensation (536)
Complete response letters (21)
COVID-19 (2717)
CRISPR (41)
C-suite (252)
Cystic fibrosis (101)
Data (2234)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (277)
Diagnostics (6583)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (106)
Drug shortages (28)
Duchenne muscular dystrophy (95)
Earnings (88786)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (117424)
Executive appointments (740)
FDA (18293)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (769)
Gene editing (108)
Generative AI (25)
Gene therapy (308)
GLP-1 (761)
Government (4687)
Grass and pollen (4)
Guidances (67)
Healthcare (19902)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (30)
Infectious disease (2865)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (319)
IPO (16875)
IRA (41)
Job creations (4045)
Job search strategy (1501)
Kidney cancer (10)
Labor market (38)
Layoffs (485)
Leadership (18)
Legal (8465)
Liver cancer (78)
Lung cancer (329)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (312)
MASH (70)
Medical device (14384)
Medtech (14389)
Mergers & acquisitions (20212)
Metabolic disorders (722)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (99)
Neuropsychiatric disorders (31)
Neuroscience (2002)
NextGen: Class of 2025 (6911)
Non-profit (4740)
Now hiring (39)
Obesity (387)
Opinion (218)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (84)
Parkinson's disease (153)
Partnered (21)
Patents (236)
Patient recruitment (114)
Peanut (48)
People (60163)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21134)
Phase II (29839)
Phase III (22302)
Pipeline (1215)
Policy (142)
Postmarket research (2741)
Preclinical (9025)
Press Release (67)
Prostate cancer (109)
Psychedelics (32)
Radiopharmaceuticals (256)
Rare diseases (390)
Real estate (6304)
Recruiting (65)
Regulatory (23712)
Reports (46)
Research institute (2482)
Resumes & cover letters (359)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (76)
Series A (131)
Series B (87)
Service/supplier (13)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3831)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (40)
The Weekly (32)
Vaccines (729)
Venture capitalists (42)
Weight loss (262)
Women's health (38)
Worklife (16)
Date
Today (148)
Last 7 days (912)
Last 30 days (2649)
Last 365 days (33550)
2025 (10975)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (794)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (41017)
Australia (6757)
California (6193)
Canada (2027)
China (543)
Colorado (278)
Connecticut (291)
Delaware (152)
Europe (88887)
Florida (920)
Georgia (214)
Idaho (61)
Illinois (576)
India (26)
Indiana (314)
Iowa (11)
Japan (165)
Kansas (107)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (935)
Massachusetts (4671)
Michigan (227)
Minnesota (405)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (65)
New Hampshire (68)
New Jersey (1760)
New Mexico (29)
New York (1769)
North Carolina (1037)
North Dakota (8)
Northern California (2701)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1387)
Puerto Rico (12)
Rhode Island (35)
South America (1185)
South Carolina (24)
South Dakota (1)
Southern California (2323)
Tennessee (103)
Texas (921)
United States (23645)
Utah (184)
Virginia (150)
Washington D.C. (65)
Washington State (572)
West Virginia (3)
Wisconsin (56)
736,539 Results for "isoray medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.
GT Medical Technologies, Inc. (GT MedTech) announces the successful acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc.
April 15, 2024
·
5 min read
Deals
GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.
GT Medical Technologies, Inc. (“GT Medical Technologies”), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced it has agreed to acquire substantially all of the radioactive Cesium-131 seed assets and related business infrastructure from Isoray Medical, which is a subsidiary of Perspective Therapeutics, Inc. (“Isoray”).
December 12, 2023
·
6 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
April 29, 2025
·
2 min read
Press Releases
Transverse Medical Inc. Announces Completion of Series B2 Capital Raise
April 29, 2025
·
2 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 30, 2025
·
1 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Press Releases
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
April 28, 2025
·
1 min read
Press Releases
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
April 9, 2025
·
3 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
1 of 73,654
Next
